Amended Pharmaceutical care of people with rheumatoid arthritis. Course information. Contents of pack
|
|
- Joseph Barnett
- 5 years ago
- Views:
Transcription
1 Pharmaceutical care of people with rheumatoid arthritis. Course information. Contents of pack Your pack contains: Pharmaceutical care of people with rheumatoid arthritis course information. Pharmaceutical care of people with rheumatoid arthritis course activities. Pharmaceutical care of people with rheumatoid arthritis course resources. Set of pharmaceutical care needs assessment tools for rheumatoid arthritis (10). Plan & record form. Freepost envelope. CD-ROM Video presentation. Acknowledgements This pack was brought together with the help of Carole Callaghan. Special thanks to Kathryn Wilson and Carolyn Dawson. Disclaimer While every precaution has been taken in the preparation of these materials, neither NES nor external contributors shall have any liability to any person or entity with respect to liability, loss or damage caused or alleged to be caused directly or indirectly by the information therein. CD-ROM The CD-ROM with Carole Callaghan s presentation will work on a PC which runs Windows 98 or later and has: a CD-ROM drive a Windows Media player version 9 or later a soundcard with speakers or headphones a web browser, such as Internet Explorer 5.0 or later, or Netscape Navigator 7 or later. Insert the CD- ROM in your computer and wait a little while. The CD-ROM starts automatically and will show the opening page in the browser window. (You may be prompted to download some additional software.) Click on play to run the presentation. If the CD-ROM doesn t work in autostart mode (or if you want to run it on Apple Macintosh), open the CD- ROM and double-click on the file XXX.htm. 1
2 Introduction Pharmaceutical care of people with rheumatoid arthritis This course offers Scottish pharmacists training on how they can contribute to the care of people with rheumatoid arthritis as part of their normal working practice by applying the principles of pharmaceutical care for patients with chronic diseases. This invaluable training for community pharmacists will help prepare them for the future and should link with previous NES Core Course materials and any local medication review training. The evening will start with a lecture on rheumatoid arthritis and it s management. This will be delivered by a practitioner with a special interest in chronic pain. This will cover definition, pathophysiology, diagnosis, management and common pharmaceutical care issues. The workshops will take the form of very practical patient assessments followed by group discussion. To help with integrated care this course is of interest to pharmacists working within all care settings. Aim To update pharmacists on the current management of rheumatoid arthritis and explore ways to implement pharmaceutical care for this patient group as part of normal working practice. Objectives At the end of the session pharmacists should be able to: describe the common signs and symptoms associated with rheumatoid arthritis define the current therapeutic management for both the alleviation of symptoms and for modifying disease progression in rheumatoid arthritis identify pharmaceutical care issues and appropriate management solutions when responding to symptoms in patient scenarios explore how to implement the principles of a pharmaceutical care needs assessment tool in practice. 2
3 Pre-course reading Klareskog L, Catrina AI and Paget S. Rheumatoid arthritis. Lancet 2009; 373: Scottish Intercollegiate Guidelines Network (SIGN) (2004) Management of Early Rheumatoid Arthritis. Edinburgh, SIGN. Luqmani R, Hennell S, Estrach C, Birrell F, Bosworth A, Davenport G et al on behalf of the British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group. British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (The first 2 years). Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A et al on behalf of the British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group. British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Rheumatoid Arthritis (After the first 2 years). Pharmaceutical care needs assessment (PCNA) tool Aide Memoire for PCNA CPD Plan & Record Form. In addition, it is recommended that you update yourself on the section on NSAIDs and Disease-Modifying Anti-Rheumatic Drugs (DMARDs) 3
4 in the current BNF, along with any local guidelines that exist within your NHS Board for these agents, before coming along to the course. Background Rheumatoid arthritis (RA) is one of the commonest autoimmune diseases. It is a chronic, progressive, systemic inflammatory disorder affecting the synovial joints and typically producing symmetrical arthritis. If left untreated, it leads to joint destruction, which is responsible for the deformity and disability seen in this disease. The disease therefore exerts a considerable burden on society in terms of direct (e.g. medical care) and indirect costs (e.g. effects on the individuals is the potential loss of social and financial independence). The prevalence of RA is consistent worldwide, affecting about 0.5 1% of the population. Although the disease affects people all over the world, certain populations demonstrate particularly low or high prevalence (inhabitants of sub-saharan Africa and native Americans respectively). As with other autoimmune conditions, women are affected more than men at a ratio of 3:1. The goals of RA management are to relieve pain and inflammation, prevent joint destruction, preserve or improve functional ability, and maintain a patient s normal lifestyle. There has been a major shift in the treatment of RA over the past decade. Traditionally, the therapeutic pyramid was employed, whereby initial treatment was conservative, using non-steroidal antiinflammatory drugs (NSAIDs) for several years and only progressing to disease modifying anti-rheumatic drugs (DMARDs) when the disease was not controlled. This approach has been replaced by early treatment with DMARDs, because there is evidence that most patients develop joint destruction within the first two years of their disease. Implementing the pharmaceutical care needs assessment tool A pharmaceutical care needs assessment tool for rheumatoid arthritis has been developed to help pharmacists apply their learning, develop their assessment skills and help their patients get the most out of their medication and reduce any associated risks. It incorporates a simple assessment and follows the same systematic inquiry 4
5 as the other chronic condition PCNA tools in the previous NES Core Courses by suggesting questions that will allow you to confirm the person s understanding of their condition and or how their medication works, effectiveness (sub-optimal dose or additional medication required), safety (adverse drug reactions, interactions or toxicity) and intentional or non-intentional non-compliance. As people present with their prescriptions for medication used in the treatment of rheumatoid arthritis, confirm their diagnosis and as part of the normal clinical check and counselling process ask if they would like to answer some more in depth questions about their condition. This will help to ensure that they are getting the best from their medication and that they are not at risk of any adverse effects. You can then work through the assessment tool as a single intervention or it can be completed as the person visits the pharmacy with a repeat prescription over subsequent weeks or months. The assessment tool has been designed with direct patient contact in mind and will help pharmacists to speak with patients in a more systematic and focused way. You can adapt the questions to your own style and the needs of your patients. Use it in conjunction with your computerised pharmacy medication records to identify patients you would like to actively target e.g. people over the age of 65 prescribed regular NSAIDs. The aide memoire suggests ways to optimise information provision and drug treatment by summarising key points to help pharmacists support and advise the patient or carer and suggests when it may be appropriate to refer to their GP or nurse. Using this tool will help you to further develop your patient assessment skills and more therapeutic relationships with your patients and medical and nursing colleagues. 5
6 Teaching plan Lecture Rheumatoid Arthritis 30 minutes and 10 minutes discussion This talk will cover: definition and pathophysiology diagnosis signs and symptoms guidance on management Comfort break 15 minutes Workshops 60 mins Training groups should be divided into groups of between 12 and 15 participants. One facilitator should be assigned to this group, which will then be further subdivided into smaller groups of three to five. Case 1 & 2: volunteers for each case, one participant chosen to play the patient and one to play the pharmacist who completes the case using the pharmaceutical care needs assessment tool. Remaining participants will observe. The group will identify care issues at the end of the role play (10 minute role play with 5 minutes discussion). Each group should do both cases, if possible. Case 3 & 4 : workshop: the small groups work through these together (10 minutes with 5 minutes discussion). Questions/discussion/answers 10 minutes in large groups. Answers should be provided at the end of the session. Summary 10 minutes CPD-action (recording), evaluation and identification of further training needs. Using the spare assessment tools to explore how to implement the tool in practice. Local pain services and support. Course assessment. 6
Pharmaceutical care of stroke patients Course information
Pharmaceutical care of stroke patients Course information Contents of pack Your pack contains: Pharmaceutical care of stroke patients Course information Pharmaceutical care of stroke patients Course activities
More informationPharmaceutical care of stroke patients Course information
Pharmaceutical care of stroke patients Course information Contents of pack Your pack contains: Pharmaceutical care of stroke patients Course information Pharmaceutical care of stroke patients Course activities
More informationWhat is Rheumatoid Arthritis?
What is Rheumatoid Arthritis? Rheumatoid arthritis (RA) is an autoimmune condition in which the immune system attacks the joint tissue causing inflammation, stiffness, pain and extreme fatigue. If left
More informationNational Institute for Health and Clinical Excellence SCOPE. Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults
National Institute for Health and Clinical Excellence 1 Guideline title SCOPE Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults 1.1 Short title Rheumatoid arthritis 2
More informationPharmaceutical Care of People with Atrial Fibrillation. Course information
Pharmaceutical Care of People with Atrial Fibrillation Course information Pharmaceutical Care of People with Atrial Fibrillation Course information page 3 Introduction 5 Teaching plan 6 Needs Assessment
More informationPharmaceutical care of people with coronary heart disease
Pharmaceutical care of people with coronary heart disease Course information Pharmaceutical care of people with coronary heart disease Course information 2 Contents of pack 3 Introduction 7 Teaching plan
More informationA framework for all staff working with people with Autism Spectrum Disorders, their families and carers
A framework for all staff working with people with Autism Spectrum Disorders, their families and carers Autism Strategy Collaborative Business Meeting & Development Workshop Glasgow, 29 th April 2015 To
More informationRosemary Plum Prescriptive Solutions Ltd SIMPLE Respiratory 2015
+ A SERVICE FOR COMMUNITY PHARMACY Rosemary Plum Prescriptive Solutions Ltd + n Why Pharmacy? High patient footfall 450 diagnosed asthma patients Walk-in service Medicines skills and expertise Structured
More informationA guide to essential gluten-free foods available from the pharmacy
A guide to essential gluten-free foods available from the pharmacy This information guide has been produced by For further information: This resource has been reviewed by the British Dietetic Association.
More informationProScript User Guide. Pharmacy Access Medicines Manager
User Guide Pharmacy Access Medicines Manager Version 3.0.0 Release Date 01/03/2014 Last Reviewed 11/04/2014 Author Rx Systems Service Desk (T): 01923 474 600 Service Desk (E): servicedesk@rxsystems.co.uk
More informationFacilitator s Manual to the Interactive Performance Oriented Mobility Assessment (ipoma)
Facilitator s Manual to the Interactive Performance Oriented Mobility Assessment (ipoma) November 2005 Facilitator s Manual to the Interactive Geriatric Assessment Lite Modules Table of Contents Description
More informationNorth of England Cancer Network. Policies and Procedures. Standards for the Safe Use of Oral Anticancer Medicines
\ North of England Cancer Network Policies and Procedures Standards for the Safe Use of Oral Anticancer Medicines NECN Oral Anticancer medicine Policy version 1.6 Page 1 of 17 Issue Date: Feb 2017 Contents
More informationTHE ME TRUST. Vision into Action Strategy: Summary
THE ME TRUST 2018-2021 Strategy: Summary Vision into Action Until there is a cure, The ME Trust is determined to deliver on a strategy that enables people with ME/CFS across the UK to receive appropriate,
More informationImproving quality of care for epilepsy patients using a pharmacist review service
Improving quality of care for epilepsy patients using a pharmacist review service Carole Brown MSc (Clin Pharm), PIP, PwSI Epilepsy, MRPharmS A structured review process for epilepsy in primary care has
More informationIMMEDIATE DICLOFENAC NEW CONTRAINDICATIONS AND WARNINGS AFTER A EUROPE-WIDE REVIEW OF CARDIOVASCULAR SAFETY
Finance, EHealth and Pharmaceuticals Directorate Pharmacy and Medicines Division T: 0131-244 2528 E: irene.fazakerley@scotland.gsi.gov.uk 1. Medical Directors 2. Directors of Public Health 3. Directors
More informationWhat is a Knowledge Network? What is a Knowledge Network? Changing Outcomes through a Knowledge Network. Knowledge 09/08/06.
What is a Knowledge Network? Changing Outcomes through a Knowledge Network Dr. Peter Martin Clinical Director of Palliative Care (Barwon Health) Chair (Knowledge Network Management Group) Senior Lecturer(Hon),
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationInstructor s Guide to Dementia Screening: The Mini-Mental State Exam (M.M.S.E.) September 2005
Instructor s Guide to Dementia Screening: The Mini-Mental State Exam (M.M.S.E.) September 2005 Page 1 of 6 Instructor s Guide to Dementia Screening: The Mini- Mental State Exam (M.M.S.E.) Description of
More informationNHS Circular: PCA(M)(2011)4 abcdefghijklmnopqrstu TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH SEVERE DISTRESS. Summary
Directorate for Health and Social Care Integration Primary Care NHS Circular: abcdefghijklmnopqrstu Dear Colleague LIST OF DRUGS SUBJECT TO PRESCRIBING TREATMENT OF ERECTILE DYSFUNCTION: PATIENTS WITH
More informationConsultation Group: Dr Amalia Mayo, Paediatric Consultant. Review Date: March Uncontrolled when printed. Version 2. Executive Sign-Off
Policy For The Adjustment Of Insulin Injections By Paediatric Diabetes Specialist Nurses/Community Paediatric Nurses Diabetes Working With Children Within NHS Grampian Co-ordinators: Lead Paediatric Diabetes
More informationPfizer Independent Grants for Learning & Change Request for Proposals (RFP) Rheumatoid Arthritis Mono- and Combination DMARD Therapy in RA Patients
Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Rheumatoid Arthritis Mono- and Combination DMARD Therapy in RA Patients I. Background The mission of Pfizer Independent Grants
More informationAzathioprine treatment for respiratory conditions. Information for patients Respiratory Medicine - Asthma
Azathioprine treatment for respiratory conditions Information for patients Respiratory Medicine - Asthma What is azathioprine? Azathioprine (also known as Imuran) is a treatment for the immune system.
More informationErelzi (etanercept) Frequently Asked Questions
Erelzi (etanercept) Frequently Asked Questions 1. What is the funding status of Erelzi (etanercept)? Effective December 21, 2017, Erelzi (etanercept) will be added to the Ontario Drug Benefit (ODB) Formulary
More informationUnderstanding Rheumatoid Arthritis
Understanding Rheumatoid Arthritis Contents Introduction...3 What is rheumatoid arthritis?...4 Symptoms of rheumatoid arthritis... 5 What causes rheumatoid arthritis?... 10 The role of genes and family
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Diabetes dietary review Potential output: Recommendations
More informationCPD Assessment Guide. PORTFOLIO ASSESSMENT A Guide to CPD Assessment
CPD Assessment Guide PORTFOLIO ASSESSMENT A Guide to CPD Assessment Version 7: June2017 1 CONTENTS SCHEDULED LEARNING Guidance Notes for Reflection Questions 1&2...3 Guidance Notes for Planning Questions
More informationAbatacept. What is abatacept?
What is abatacept? Abatacept (trade name Orencia) is a type of drug called a biological therapy. It works by stopping the function of a particular cell in the immune system (called a T-cell). This prevents
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Single Technology Appraisal (STA)
Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology
More informationGuide to Understanding and Managing Arthritis
Guide to Understanding and Managing Arthritis The content in this guide is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician
More informationUK Inflammatory Bowel Disease Audit. A summary report on the quality of healthcare provided to people with inflammatory bowel disease
UK Inflammatory Bowel Disease Audit A summary report on the quality of healthcare provided to people with inflammatory bowel disease Section heading UK IBD Audit summary report 2014 This summary report
More information1. NHS (GENERAL DENTAL SERVICES) (SCOTLAND) AMENDMENT REGULATIONS AMENDMENT NO 136 TO THE STATEMENT OF DENTAL REMUNERATION
MEMORANDUM TO NHS: PCA(D)(2017)6 DENTISTS/DENTAL BODIES CORPORATE NATIONAL HEALTH SERVICE GENERAL DENTAL SERVICES 1. NHS (GENERAL DENTAL SERVICES) (SCOTLAND) AMENDMENT REGULATIONS 2017 2. AMENDMENT NO
More informationHealth Care Providers Action Guide
Health Care Providers Action Guide Health Care Providers Action Guide How to Implement Exercise is Medicine in Your Practice This Exercise is Medicine Health Care Providers Action Guide provides simple
More informationHIGH BLOOD PRESSURE. How can we do better?
HIGH BLOOD PRESSURE How can we do better? Review date: February 2018 This publication includes practical guidance from GPs, nurses and pharmacists on how you can improve detection and management of high
More informationSmoking cessation interventions and services
National Institute for Health and Care Excellence Guideline version (Final) Smoking cessation interventions and services [E] Evidence reviews for advice NICE guideline NG92 Evidence reviews FINAL These
More informationPatient and Public Reference Group for Medicines ADTC Sub-group NHS Tayside 17 th February 2015
Patient and Public Reference Group for Medicines ADTC Sub-group NHS Tayside 17 th February 2015 Claire James, Senior Pharmacist Clinical Effectiveness, Ninewells Hospital Aims To increase awareness and
More informationGuidelines for the appointment of. General Practitioners with Special Interests in the Delivery of Clinical Services. Epilepsy
Guidelines for the appointment of General Practitioners with Special Interests in the Delivery of Clinical Services Epilepsy April 2003 Epilepsy This general practitioner with special interest (GPwSI)
More information1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.
SHARED CARE GUIDELINE FOR ACAMPROSATE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of
More informationSafe, effective, affordable drug choices: online tool for payers and patients.
Executive summary: Rising healthcare costs and greater access to medical information drive patients to seek options for their drug therapy. The MedAlternatives database by Gold Standard/Elsevier empowers
More informationWELSH HEALTH CIRCULAR
WELSH HEALTH CIRCULAR WHC (2018) 015 Issue Date: 5 April 2018 STATUS: ACTION CATEGORY: PUBLIC HEALTH Title: Ordering adjuvanted flu vaccine for the 2018-19 season Date of Expiry / Review N/A For Action
More informationHorizon Scanning Technology Summary. Adalimumab (Humira) for juvenile idiopathic arthritis. National Horizon Scanning Centre.
Horizon Scanning Technology Summary National Horizon Scanning Centre Adalimumab (Humira) for juvenile idiopathic arthritis June 2007 This technology summary is based on information available at the time
More informationGLUTEN-FREE FOOD SCHEME. Information Pack
GLUTEN-FREE FOOD SCHEME Information Pack The Tayside Gluten-Free Food Scheme is part of the Scottish Gluten-Free Food Service. There are variations from the Scottish Service and more information can be
More informationScottish Medicines Consortium
Scottish Medicines Consortium ketoprofen/, 100mg/20mg; 200mg/20mg modified release capsules (Axorid ) No. (606/10) Meda Pharmaceuticals 05 February 2010 The Scottish Medicines Consortium (SMC) has completed
More informationAzathioprine. Drug information. Azathioprine is used to treat rheumatoid arthritis, lupus and other conditions.
Azathioprine Drug information Azathioprine is used to treat rheumatoid arthritis, lupus and other conditions. Azathioprine should help treat your condition. It has been in use for many years and has helped
More informationSmoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014
Smoking Counselling and Cessation Service in Hospital Authority 7 May 2014 - HA Convention 2014 On behalf of COC (Family Medicine) Dr Maria Leung Consultant, Department of Family Medicine New Territories
More informationAll Saints First School Administering of Medicines Policy
All Saints First School Administering of Medicines Policy Success Indicators The following indicators will demonstrate the level of compliance with this policy and its procedures: a) Employees who are
More informationREPORT FROM ANNUAL CARER CONFERENCE CARERS HEALTH MATTERS. Hilton Strathclyde Hotel, Bellshill
REPORT FROM ANNUAL CARER CONFERENCE CARERS HEALTH MATTERS Hilton Strathclyde Hotel, Bellshill 3 rd November 2014 North Lanarkshire Carers Together annual conference took place in the Hilton Strathclyde
More informationUsing ENBREL to Treat Rheumatoid and Psoriatic Arthritis
Using ENBREL to Treat Rheumatoid and Psoriatic Arthritis Writing White Papers class Bellevue Community College TABLE OF CONTENTS TABLE OF CONTENTS...2 OVERVIEW...3 RHEUMATOID ARTHRITIS... 3 JUVENILE RHEUMATOID
More informationDisease Modifying Anti-Rheumatic Medications (DMARDS) Monitoring Clinic
Department of Rheumatology Portsmouth Hospitals NHS Trust Disease Modifying Anti-Rheumatic Medications (DMARDS) Monitoring Clinic Patient Information Leaflet Specialist Support This leaflet can be made
More informationHorizon Scanning Technology Summary. Abatacept (Orencia) for juvenile idiopathic arthritis. National Horizon Scanning Centre.
Horizon Scanning Technology Summary National Horizon Scanning Centre Abatacept (Orencia) for juvenile idiopathic arthritis June 2007 This technology summary is based on information available at the time
More informationEarly Inflammatory Arthritis Pathway Rheumatology Service Commissioner Lead
Schedule 2 Part A Service Specification Number 04/MSKT/0014 Care Pathway/Service Early Inflammatory Arthritis Pathway Rheumatology Service Commissioner Lead CCP for Musculoskeletal & Trauma Provider Lead
More informationNAS NATIONAL AUDIT OF SCHIZOPHRENIA. Second National Audit of Schizophrenia What you need to know
NAS NATIONAL AUDIT OF SCHIZOPHRENIA Second National Audit of Schizophrenia What you need to know Compiled by: Commissioned by: 2 October 2014 Email: NAS@rcpsych.ac.uk The National Audit of Schizophrenia
More informationAdditional details about you What is your ethnic group? Name of next of kin \ Emergency contact
Thank you for applying to join The Hedges Medical Centre. We would like to gather some information about you and ask that you fill in the following questionnaire. You don t have to supply answers to all
More informationWhy is this important for you? Types of arthritis. Information for the public Published: 28 February 2017 nice.org.uk
Spondyloarthritis in over 16s: diagnosis and management Information for the public Published: 28 February 2017 nice.org.uk Spondyloarthritis: the care you should expect This information explains the care
More informationInformation Sheet 10. Medication Hints and Tips (Updated August 2014)
An information sheet on Medication problems and how to prevent them. Memory Loss... People who suffer from dementia or Alzheimer s disease may simply forget to take their medications, causing them to skip
More informationHorizon Scanning Centre November Secukinumab for active and progressive psoriatic arthritis. SUMMARY NIHR HSC ID: 5330
Horizon Scanning Centre November 2012 Secukinumab for active and progressive psoriatic arthritis. SUMMARY NIHR HSC ID: 5330 Secukinumab is a high-affinity fully human monoclonal antibody that antagonises
More informationAbatacept (Orencia) for active rheumatoid arthritis. August 2009
Abatacept (Orencia) for active rheumatoid arthritis August 2009 This technology summary is based on information available at the time of research and a limited literature search. It is not intended to
More informationArthritis. Canada s most common chronic health condition. About the Arthritis Society
About the Arthritis Society The Arthritis Society is a national health charity, fueled by donors and volunteers, with a vision to live in a world where people are free from the devastating effects that
More informationCommunity Pharmacy Asthma Audit 2016/17. Contents
Community Pharmacy Contents Community Pharmacy... 1 Executive Summary... 2 Introduction... 4 Background... 4 Method... 5 Results... 5 Section One: Community Pharmacy Guidelines Awareness and Training...
More informationPain relief after day surgery
Pain relief after day surgery Anaesthetics Department Patient Information Leaflet Introduction This leaflet is to help you with pain relief after you have day surgery. It gives information on: The types
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationNES Asthma Hospital Medication Care Plan 7
NES Asthma Hospital Medication Care Plan 7 PATIENT DETAILS Name Liz Duncan Address Consultant Gender Female Weight 60kg Height 1.6m General Practitioner Dr Jones Community Pharmacist Date of Birth (Age)
More informationArthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis
Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis Issued: August 2007 www.nice.org.uk/ipg230 Copyright NICE 2007 Contents 1 Guidance... 3 2 The procedure... 4
More informationDeciding what to do about Rheumatoid Arthritis
Shared Decision Making rheumatoid arthritis Next clinical review date March 2018 Deciding what to do about Rheumatoid Arthritis This short decision aid is to help you decide what treatment to have if you
More informationDr. Karim Khan, Professor of Sports Medicine, Editor of the British Journal of Sports Medicin
11Although evidence for exercise as a major public health preventive approach and a potent medical therapy is widely recognized, the challenge is to get the right information to the right patient at the
More informationE-portfolio guide. This guide will take you through, step by step, the type of information we expect you to record at each stage of your cycle.
E-portfolio guide The e-portfolio is designed to help you become a reflective learner and to emphasise the knowledge you are picking up on a daily basis. This guide will take you through, step by step,
More informationService Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian
Service Level Agreement for the Provision of Level 1 Substance Misuse Services from a Community Pharmacy under contract to NHS Grampian 1. Introduction The provision of Substance Misuse (SM) services through
More informationA Guide to the Scottish Medicines Consortium
A Guide to the Scottish Medicines Consortium Providing advice about newly licensed medicines www.scottishmedicines.org About the Scottish Medicines Consortium The Scottish Medicines Consortium (SMC) provides
More informationGoals of Diabetes Education Train the Trainer
Goals of Diabetes Education Train the Trainer Phil Unsworth Diabetes Education Nurse Facilitator Novo Nordisk Date of preparation: June 2016 UK/DB/0616/0125 Goals of Diabetes Education Training the Trainer
More informationSafe Treatment with Oral Methotrexate A Shared Responsibility Demanding a Shared Solution?
Safe Treatment with Oral Methotrexate A Shared Responsibility Demanding a Shared Solution? Tim Delaney, B.Sc.(Pharm.), M.Sc. Mgmt (O.B.), FPSI Programme Lead - Medication Safety Quality & Patient Safety
More informationSyllabus. The University of Florida College of Pharmacy's Pharmacist Immunization Program contains the following modules:
Syllabus PHARMACIST IMMUNIZATION PROGRAM UNIVERSITY OF FLORIDA COLLEGE OF PHARMACY The University of Florida is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing
More informationSection 1: Contact details Name of practice or organisation (e.g. charity) NHS Milton Keynes Clinical Commissioning Group and partners
Section 1: Contact details Name of practice or organisation (e.g. charity) NHS Milton Keynes Clinical Commissioning Group and partners Title of person writing the case study Neighbourhood Pharmacist &
More informationA Lancet Oncology Commission Greg Rubin Professor of General Practice and Primary Care
The expanding role of primary care in cancer control A Lancet Oncology Commission Greg Rubin Professor of General Practice and Primary Care Health services striving for affordable cancer care seek optimal
More informationThis standard is not designed to be prescriptive of how, when or in what format training is delivered although, some guidelines are included.
Using Medicines (or medicines refresher) This is a training standard developed for the National Training Service (NTS) Alliance. This standard has been written in consultation with subject matter experts.
More informationDocument Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml
Title Document Details Patient Group Direction (PGD) Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml Trust Ref No 1445-36348 Local Ref (optional) Main points the document The treatment of
More informationAudit on follow-up of patients with primary Osteoporosis
Abstract Aim: To document the frequency of Dual-energy X- ray absorptiometry (DEXA) scanning and Rheumatology clinic follow-up visits of patients with primary osteoporosis, and compare these with recommended
More informationRheumatology Residency Rotation University of Colorado Health Sciences Center
2010 Rheumatology Residency Rotation University of Colorado Health Sciences Center This paragraph only applies if you are rotating at the University of Colorado Hospital. Please review the rest of the
More informationDear Colleagues, NATIONAL STANDARD FOR MONITORING THE PHYSICAL HEALTH OF PEOPLE BEING TREATED WITH LITHIUM
Directorate of Chief Medical Officer T: 0131-244 6930 E: john.mitchell4@gov.scot Dear Colleagues, NATIONAL STANDARD FOR MONITORING THE PHYSICAL HEALTH OF PEOPLE BEING TREATED WITH LITHIUM Lithium is a
More informationProfessional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines
5 Continuing Professional Development: proposals for assuring the continuing fitness to practise of osteopaths draft Peer Discussion Review Guidelines February January 2015 2 draft Peer Discussion Review
More informationPROCEDURE FOR BLOOD GLUCOSE MONITORING
PROCEDURE FOR BLOOD GLUCOSE MONITORING First Issued Issue Version Two Purpose of Issue/Description of Change Planned Review Date To promote safe and effective blood glucose monitoring using Trust equipment
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationSHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN
SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the
More informationHIGHLANDS SURGERY NEWSLETTER
HIGHLANDS SURGERY NEWSLETTER Spring 2017 Inside This Issue 1 Virtual GP service (babylon) 2 Website Did Not Attend 3 Who to contact when you are not feeling well 4 Who to contact when you are not feeling
More informationActivity Report April 2012 to March 2013
North, South East and West of Scotland Cancer Networks Brain/Central Nervous System Tumours National Managed Clinical Network Activity Report April 2012 to March 2013 Professor Roy Rampling Emeritus Professor
More informationStructured diabetes patient education in Scotland
Dr Joan McDowell PhD, MN, Diploma in Nursing, RN, SCM, DN, Senior Lecturer, College of Medical, Veterinary & Life Sciences, School of Medicine, Nursing & Health Care, Glasgow, UK Professor Sandra MacRury
More informationProducts available Methotrexate tablets 2.5mg ONLY (Methotrexate tablets 10mg are NOT recommended as per NPSA guidance 5 ).
Methotrexate Traffic light classification- Amber 1 Information sheet for Primary Care Prescribers Part of the Shared Care Protocol: Management of Rheumatological Conditions with Disease-Modifying Anti
More informationNHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10.
PRESCRIBING COMMISSIONING POLICY: DENTAL CONDITIONS NHS West Cheshire Clinical Commissioning Group does not fund the prescribing for dental conditions on FP10. Note: Patients who are not eligible for treatment
More informationLipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention)
Lipid Lowering in patients with High Risk of Cardiovascular Disease (Primary Prevention) Policy Statement: October 2010 This policy defines the decision made by NHS Wirral following an evidence review
More informationGETTING THE RIGHT MEDICINE: WHAT CAN PHARMACY AND PHARMACOLOGY DEGREES OFFER?
GETTING THE RIGHT MEDICINE: WHAT CAN PHARMACY AND PHARMACOLOGY DEGREES OFFER? Dr James Desborough Senior Lecturer in Pharmacy Practice 12 June 2017 WHAT I WILL COVER WHY ARE MEDICINES IMPORTANT? THE JOURNEY
More informationA Step in the Right Direction. What People Living with Arthritis in Scotland want from their Politicians
A Step in the Right Direction What People Living with Arthritis in Scotland want from their Politicians ARTHRITIS IS THE BIGGEST CAUSE OF PAIN AND PHYSICAL DISABILITY IN SCOTLAND Arthritis is not just
More informationTHE CIMZIA PATIENT GUIDE. what you need to know to get started. For internal use only. CZP-PRM :GPSRC Patient Starter Kit
THE CIMZIA PATIENT GUIDE what you need to know to get started For internal use only. CZP-PRM-005483:GPSRC Patient Starter Kit What this booklet is for You re reading this booklet because you have been
More informationARMA Networks: Induction Pack
ARMA Networks: Induction Pack The Purpose of this Induction Pack This pack is designed for the Arthritis and Musculoskeletal Alliance (ARMA) Network groups. It has been created to act as a guide to provide
More informationNHS Dumfries & Galloway Ferrous Salt Review Protocol November 09
Title of Project: NHS Dumfries & Galloway Ferrous Salt Review Protocol November 09 1 Reason for the review Choice of iron preparation is based on cost and incidence of side effects (BNF). There is little
More informationNursing in Scotland. Glasgow & Clyde Weight Management Service
Nursing in Scotland Glasgow & Clyde Weight Management Service Contact: Dr Marie L Prince Chartered Clinical Psychologist marie.prince@ggc.scot.nhs.uk GCWMS Ward 23 Surgical Block Glasgow Royal Infirmary
More informationSafeguarding Annual Report
Safeguarding Annual Report 2016-17 Antony Heselton Head of Safeguarding and Prevent Lead 2016-2017 June 2017 1 Contents 1. Executive Summary. 3&4 2. Standards. 4&5 3. Action Plan Review. 5 4. Activity.
More informationProfessional learning: Helping children who are experiencing mental health difficulties Topic 1: Understanding mental health. Leadership team guide
4 component Professional learning: Helping children who are experiencing mental health difficulties Topic 1: Understanding mental health Leadership team guide Acknowledgement: KidsMatter Australian Early
More informationSCHEDULE 2 THE SERVICES
SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination
More informationOPAS OSTEOARTHRITIS PROGRAMME AT SPORTS SURGERY CLINIC.
Specialists in Joint Replacement, Spinal Surgery, Orthopaedics and Sport Injuries OPAS AT SPORTS SURGERY CLINIC www.sportssurgeryclinic.com INTRODUCTION Osteoarthritis Normal Joint Destruction of Cartilage
More informationPhysical Activity for Health Questionnaire
Physical Activity for Health Questionnaire This short survey is investigating Scottish medical students knowledge of the physical activity guidelines for different age groups and their confidence in applying
More informationPATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )
PATIENT GROUP DIRECTION Administration of: Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif ) By: Practice Nurses In: General Practice It is the responsibility of the professional working under
More informationSubstance use and misuse
An open learning programme for pharmacists and pharmacy technicians Substance use and misuse Educational solutions for the NHS pharmacy workforce DLP 160 Contents iii About CPPE open learning programmes
More information